Infliximab for the Treatment of Inflammatory Labyrinthitis: A Retrospective Cohort Study

Infliximab for the Treatment of Inflammatory Labyrinthitis: A Retrospective Cohort Study

Inflammatory labyrinthitis is defined as a fluctuant vestibulo-cochlear syndrome associated with an impairment of the blood-labyrinthine barrier (BLB) on delayed FLAIR MRI sequences. Systemic and intratympanic corticosteroids are the gold standard treatment but their effect is frequently insufficien...

Full description

Bibliographic Details
Main Authors: Cassandre Djian, Karine Champion, Nicolas Lai, Ludovic Drouet, Blanca Amador Borrero, Audrey Depond, Stéphane Mouly, Clément Jourdaine, Philippe Herman, Michael Eliezer, Charlotte Hautefort, Damien Sène
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Journal of Clinical Medicine
Subjects:
inflammatory labyrinthitis
infliximab
hearing disorders
vestibular diseases
Online Access:https://www.mdpi.com/2077-0383/12/13/4350

Similar Items

Similar Items